AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Gary MM , Harrison DJ . Analysis of severe adverse events related to the use of mifepristone as an abortifacient. Ann Pharmacother 2006;40:191–7. Epub 27 Dec 2005. DOI 10.1345/aph.1G4812.Medwatch Form No. 3901547-4-00-01. www.cwfa.org/articIes/7282/CWA/Life/index.htm. (accessed 2006 Feb 10).3.Medwatch Form No. 41164375-1-00-01. www.cwfa.org/articles/7282/CWA/Life/index.htm. (accessed 2006 Feb 10).4.Medwatch Form No. 3877547-X-00-01. www.cwfa.org/articles/7282/CWA/Life/index.htm. (accessed 2006 Feb 10).
